Celgene Trying To Skirt $700M In FCA Claims, Relator Says
A whistleblower on Wednesday blasted Celgene Corp.'s bid to exclude evidence in a False Claims Act suit over alleged off-label marketing of two cancer drugs, telling a California federal court the pharmaceutical...To view the full article, register now.
Already a subscriber? Click here to view full article